$PCRX
Pacira BioSciences, Inc. Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000139681419000008 Filed on February 28, 2019

Income Statement

Concept	2017 Q4	2017 Q3	2017 Q2
Revenue	$79.08M	$67.34M	$70.93M
YoY Change	8.47%	-1.49%	1.86%
Cost Of Revenue	$21.30M	$18.23M	$23.81M
YoY Change	-9.85%	-57.76%	3.29%
Gross Profit	$57.78M	$49.11M	$47.12M
YoY Change	17.25%	94.85%	1.15%
Gross Profit Margin	73.07%	72.93%	66.43%
Selling, General & Admin	$39.20M	$40.64M	$39.55M
YoY Change	12.97%	11.92%	-9.43%
% of Gross Profit	67.84%	82.77%	83.93%
Research & Development	$10.00M	$11.78M	$18.86M
YoY Change	-41.52%	20.72%	101.41%
% of Gross Profit	17.31%	23.98%	40.01%
Depreciation & Amortization	$3.660M	$3.400M	$3.700M
YoY Change	12.27%	3.03%	15.63%
% of Gross Profit	6.33%	6.92%	7.85%
Operating Expenses	$70.61M	$70.91M	$86.71M
YoY Change	-6.3%	-20.53%	13.97%
Operating Profit	-$12.83M	-$3.572M	-$15.78M
YoY Change	-50.81%	-82.88%	144.88%
Interest Expense	-$3.800M	$5.127M	$5.226M
YoY Change	153.33%	220.24%	201.56%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$3.980M	-$3.933M
YoY Change	-100.0%	215.12%	170.12%
Pretax Income	$4.600M	-$7.552M	-$19.71M
YoY Change	-215.0%	-65.87%	149.53%
Income Tax	$0.00	$45.00K	$30.00K
% Of Pretax Income	0.0%
Net Earnings	$4.595M	-$7.597M	-$19.74M
YoY Change	-215.66%	-65.72%	148.09%
Net Earnings / Revenue	5.81%	-11.28%	-27.83%
Basic Earnings Per Share		-$0.19	-$0.49
Diluted Earnings Per Share	$113.3K	-$187.7K	-$490.0K
COMMON SHARES
Basic Shares Outstanding	40.57M shares	40.46M shares	40.16M shares
Diluted Shares Outstanding			40.16M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$311.3M	$294.1M	$382.4M
YoY Change	80.36%	82.56%	135.03%
Cash & Equivalents	$54.13M	$26.22M	$53.81M
Short-Term Investments	$257.2M	$267.9M	$328.6M
Other Short-Term Assets	$6.700M	$5.600M	$7.500M
YoY Change	-27.96%	-44.55%	29.31%
Inventory	$41.41M	$39.11M	$33.60M
Prepaid Expenses
Receivables	$31.66M	$27.02M	$27.47M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$391.1M	$365.8M	$451.0M
YoY Change	60.89%	55.38%	74.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$107.0M	$105.9M	$103.2M
YoY Change	5.97%	5.54%	3.99%
Goodwill	$55.20M	$52.96M	$50.94M
YoY Change	18.1%	18.55%	19.16%
Intangibles
YoY Change
Long-Term Investments	$74.20M	$80.80M
YoY Change
Other Assets	$825.0K	$545.0K	$572.0K
YoY Change	32.21%	-16.28%	-15.51%
Total Long-Term Assets	$237.3M	$240.3M	$154.8M
YoY Change	59.9%	64.89%	8.44%
TOTAL ASSETS
Total Short-Term Assets	$391.1M	$365.8M	$451.0M
Total Long-Term Assets	$237.3M	$240.3M	$154.8M
Total Assets	$628.4M	$606.1M	$605.7M
YoY Change	60.52%	59.01%	51.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.66M	$12.28M	$10.39M
YoY Change	95.15%	68.49%	125.23%
Accrued Expenses	$41.06M	$39.70M	$46.76M
YoY Change	11.98%	27.75%	21.98%
Deferred Revenue
YoY Change
Short-Term Debt	$300.0K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due		$300.0K	$300.0K
YoY Change
Total Short-Term Liabilities	$56.22M	$52.34M	$57.51M
YoY Change	25.38%	-64.36%	-61.77%
LONG-TERM LIABILITIES
Long-Term Debt	$276.2M	$272.7M	$269.3M
YoY Change	154.09%
Other Long-Term Liabilities	$16.50M	$16.23M	$17.86M
YoY Change	-12.77%	29.27%	26.1%
Total Long-Term Liabilities	$16.50M	$16.23M	$17.86M
YoY Change	-12.77%	29.27%	26.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$56.22M	$52.34M	$57.51M
Total Long-Term Liabilities	$16.50M	$16.23M	$17.86M
Total Liabilities	$348.9M	$341.3M	$344.7M
YoY Change	102.27%	104.36%	100.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$389.1M	-$393.7M	-$386.1M
YoY Change	12.39%	15.04%	20.63%
Common Stock	$41.00K	$41.00K	$40.00K
YoY Change	10.81%	10.81%	8.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	0.000 shares	0.000 shares	0.000 shares
Shareholders Equity	$279.5M	$264.8M	$261.0M
YoY Change
Total Liabilities & Shareholders Equity	$628.4M	$606.1M	$605.7M
YoY Change	60.52%	59.01%	51.17%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2017 Q2
OPERATING ACTIVITIES
Net Income	$4.595M	-$7.597M	-$19.74M
YoY Change	-215.66%	-65.72%	148.09%
Depreciation, Depletion And Amortization	$3.660M	$3.400M	$3.700M
YoY Change	12.27%	3.03%	15.63%
Cash From Operating Activities	$16.94M	-$2.810M	$3.650M
YoY Change	-2.36%	-124.06%	-51.59%
INVESTING ACTIVITIES
Capital Expenditures	-$5.080M	-$5.420M	-$5.150M
YoY Change	4.1%	38.62%	-41.94%
Acquisitions	$15.00M
YoY Change
Other Investing Activities	$13.77M	-$22.05M	-$56.00M
YoY Change	-775.0%	134.33%	419.48%
Cash From Investing Activities	$8.690M	-$27.47M	-$61.15M
YoY Change	-225.76%	106.23%	211.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.280M	2.690M	2.330M
YoY Change	113.08%	249.35%	-2.1%
NET CHANGE
Cash From Operating Activities	16.94M	-2.810M	3.650M
Cash From Investing Activities	8.690M	-27.47M	-61.15M
Cash From Financing Activities	2.280M	2.690M	2.330M
Net Change In Cash	27.91M	-27.59M	-55.17M
YoY Change	142.48%	3071.26%	467.59%
FREE CASH FLOW
Cash From Operating Activities	$16.94M	-$2.810M	$3.650M
Capital Expenditures	-$5.080M	-$5.420M	-$5.150M
Free Cash Flow	$22.02M	$2.610M	$8.800M
YoY Change	-0.94%	-83.26%	-46.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2018	dei	Document Type DocumentType	10-K
CY2018	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41229766	shares
CY2018	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q2	dei	Entity Public Float EntityPublicFloat	1300000000	USD
CY2018	dei	Entity Registrant Name EntityRegistrantName	Pacira Pharmaceuticals, Inc.
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2017Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	2053000	USD
CY2018Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	2053000	USD
CY2017Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	20646000	USD
CY2018Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	23019000	USD
CY2016	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	479000	USD
CY2017	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	1248000	USD
CY2018	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	1590000	USD
CY2016	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	3426000	USD
CY2017	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	387000	USD
CY2018	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	3000000	USD
CY2016	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	785000	USD
CY2017	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	680000	USD
CY2018	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	711000	USD
CY2016	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	24505000	USD
CY2017	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	24056000	USD
CY2018	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	21980000	USD
CY2016	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	841000	USD
CY2017	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	167000	USD
CY2018	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	663000	USD
CY2018Q4	pcrx	Contract Termination Fee ContractTerminationFee	7100000	USD
CY2017Q4	pcrx	Contract Termination Fee Current Portion ContractTerminationFeeCurrentPortion	2400000	USD
CY2018Q4	pcrx	Contract Termination Fee Current Portion ContractTerminationFeeCurrentPortion	0	USD
CY2016	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	0	USD
CY2017	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	285000	USD
CY2018	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	0	USD
CY2016	pcrx	Debt Conversion Converted Instrument Shares Issued Value DebtConversionConvertedInstrumentSharesIssuedValue	0	USD
CY2017	pcrx	Debt Conversion Converted Instrument Shares Issued Value DebtConversionConvertedInstrumentSharesIssuedValue	120960000	USD
CY2018	pcrx	Debt Conversion Converted Instrument Shares Issued Value DebtConversionConvertedInstrumentSharesIssuedValue	0	USD
CY2018	pcrx	Debt Instrument Convertible Conversion Premium Shares DebtInstrumentConvertibleConversionPremiumShares	10000	shares
CY2018Q4	pcrx	Debt Instrument Convertible Conversion Value DebtInstrumentConvertibleConversionValue	200000	USD
CY2017Q4	pcrx	Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance	120230000	USD
CY2018Q4	pcrx	Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance	118658000	USD
CY2017Q4	pcrx	Deferred Tax Assets Stock Based Compensation DeferredTaxAssetsStockBasedCompensation	16925000	USD
CY2018Q4	pcrx	Deferred Tax Assets Stock Based Compensation DeferredTaxAssetsStockBasedCompensation	18302000	USD
CY2017	pcrx	Discontinued Operations Assetsremovedfrom Service DiscontinuedOperationsAssetsremovedfromService	2470000	USD
CY2017	pcrx	Discontinued Operations Fixed Assetand Inventory Writedown DiscontinuedOperationsFixedAssetandInventoryWritedown	2470000	USD
CY2018	pcrx	Discontinued Operations Fixed Assetand Inventory Writedown DiscontinuedOperationsFixedAssetandInventoryWritedown	0	USD
CY2017	pcrx	Discontinued Operations Payments For Lease Costs DiscontinuedOperationsPaymentsForLeaseCosts	744000	USD
CY2018	pcrx	Discontinued Operations Payments For Lease Costs DiscontinuedOperationsPaymentsForLeaseCosts	1311000	USD
CY2017	pcrx	Discontinued Operations Remaining Lease Costs DiscontinuedOperationsRemainingLeaseCosts	2018000	USD
CY2018	pcrx	Discontinued Operations Remaining Lease Costs DiscontinuedOperationsRemainingLeaseCosts	1513000	USD
CY2016Q4	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	0	USD
CY2017Q4	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	1768000	USD
CY2018Q4	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	1970000	USD
CY2016	pcrx	Effective Income Tax Rate Reconciliation Convertible Senior Notes Refinancing EffectiveIncomeTaxRateReconciliationConvertibleSeniorNotesRefinancing	0.0000
CY2017	pcrx	Effective Income Tax Rate Reconciliation Convertible Senior Notes Refinancing EffectiveIncomeTaxRateReconciliationConvertibleSeniorNotesRefinancing	0.0655
CY2018	pcrx	Effective Income Tax Rate Reconciliation Convertible Senior Notes Refinancing EffectiveIncomeTaxRateReconciliationConvertibleSeniorNotesRefinancing	0.0000
CY2016	pcrx	Effective Income Tax Rate Reconciliation Effect Of New Accounting Pronouncements EffectiveIncomeTaxRateReconciliationEffectOfNewAccountingPronouncements	0.0000
CY2017	pcrx	Effective Income Tax Rate Reconciliation Effect Of New Accounting Pronouncements EffectiveIncomeTaxRateReconciliationEffectOfNewAccountingPronouncements	0.6889
CY2018	pcrx	Effective Income Tax Rate Reconciliation Effect Of New Accounting Pronouncements EffectiveIncomeTaxRateReconciliationEffectOfNewAccountingPronouncements	0.0000
CY2016	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.0081
CY2017	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.0128
CY2018	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.9204
CY2016	pcrx	Effective Income Tax Rate Reconciliation Interest Expense Percent EffectiveIncomeTaxRateReconciliationInterestExpensePercent	0.0575
CY2017	pcrx	Effective Income Tax Rate Reconciliation Interest Expense Percent EffectiveIncomeTaxRateReconciliationInterestExpensePercent	0.0290
CY2018	pcrx	Effective Income Tax Rate Reconciliation Interest Expense Percent EffectiveIncomeTaxRateReconciliationInterestExpensePercent	2.1847
CY2017Q1	pcrx	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTax	29300000	USD
CY2016	pcrx	Effective Income Tax Rate Reconciliation Tax Reserves Percent EffectiveIncomeTaxRateReconciliationTaxReservesPercent	0.0000
CY2017	pcrx	Effective Income Tax Rate Reconciliation Tax Reserves Percent EffectiveIncomeTaxRateReconciliationTaxReservesPercent	0.0000
CY2018	pcrx	Effective Income Tax Rate Reconciliation Tax Reserves Percent EffectiveIncomeTaxRateReconciliationTaxReservesPercent	-2.0298
CY2016	pcrx	Effectofstateblendedtaxratechanges Effectofstateblendedtaxratechanges	-0.0465
CY2017	pcrx	Effectofstateblendedtaxratechanges Effectofstateblendedtaxratechanges	-1.3088
CY2018	pcrx	Effectofstateblendedtaxratechanges Effectofstateblendedtaxratechanges	0.1344
CY2018Q4	pcrx	Employee Stock Purchase Plan Espp Sharesin Espp EmployeeStockPurchasePlanESPPSharesinESPP	500000	shares
CY2018Q4	pcrx	Employee Stock Purchase Plan Numberof Shares Authorized EmployeeStockPurchasePlanNumberofSharesAuthorized	500000	shares
CY2018Q4	pcrx	Employee Stock Purchase Plan Numberof Shares Available For Purchase EmployeeStockPurchasePlanNumberofSharesAvailableForPurchase	275113	shares
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-454000	USD
CY2018Q4	pcrx	Employee Stock Purchase Planfairvalue EmployeeStockPurchasePlanfairvalue	0.85
CY2016	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
CY2017	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	126328000	USD
CY2018	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
CY2017Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	59800000	USD
CY2018Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	64600000	USD
CY2017	pcrx	Goodwill Recordedfor Earn Out Payments GoodwillRecordedforEarnOutPayments	8460000	USD
CY2018	pcrx	Goodwill Recordedfor Earn Out Payments GoodwillRecordedforEarnOutPayments	6843000	USD
CY2016	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-37844000	USD
CY2017	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-42471000	USD
CY2018	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-425000	USD
CY2016	pcrx	Increase Decrease In Capital Expenditures Incurred And Not Yet Paid IncreaseDecreaseInCapitalExpendituresIncurredAndNotYetPaid	-789000	USD
CY2017	pcrx	Increase Decrease In Capital Expenditures Incurred And Not Yet Paid IncreaseDecreaseInCapitalExpendituresIncurredAndNotYetPaid	2189000	USD
CY2018	pcrx	Increase Decrease In Capital Expenditures Incurred And Not Yet Paid IncreaseDecreaseInCapitalExpendituresIncurredAndNotYetPaid	-98000	USD
CY2018Q4	pcrx	Investments Contingent Purchase Obligation InvestmentsContingentPurchaseObligation	900000	USD
CY2018Q4	pcrx	Maximum Fair Market Value Purchaseof Espp Shares MaximumFairMarketValuePurchaseofESPPShares	25000	USD
CY2018	pcrx	Minimum Cumulative Percentage Of Change In Ownership As Condition To Offset Taxable Income Or Tax MinimumCumulativePercentageOfChangeInOwnershipAsConditionToOffsetTaxableIncomeOrTax	0.5
CY2018Q4	pcrx	Non Us Net Operating Loss NonUSNetOperatingLoss	11400000	USD
CY2017	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2018	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2016	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	15857000	USD
CY2017	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	8460000	USD
CY2018	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	6843000	USD
CY2016	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	1495000	USD
CY2017	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	1862000	USD
CY2018	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	1784000	USD
CY2017Q4	pcrx	Product Returns Rebatesand Other Fees ProductReturnsRebatesandOtherFees	1972000	USD
CY2018Q4	pcrx	Product Returns Rebatesand Other Fees ProductReturnsRebatesandOtherFees	1533000	USD
CY2017Q1	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
CY2018Q4	pcrx	Sharebased Compensationarrangementby Sharebasedpaymentawardequityinstrumentsothersthanoptionsvestedandexpectedtovestweightedaveragegrantdatefairvalue SharebasedCompensationarrangementbySharebasedpaymentawardequityinstrumentsothersthanoptionsvestedandexpectedtovestweightedaveragegrantdatefairvalue	42.14
CY2018Q4	pcrx	Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestaggregateintrinsicvalue Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestaggregateintrinsicvalue	24864000	USD
CY2018	pcrx	Stock Purchased And Issued During Period Shares Employee Stock Purchase Plans StockPurchasedAndIssuedDuringPeriodSharesEmployeeStockPurchasePlans	64740	shares
CY2018	pcrx	Tax Cutsand Jobs Actof2017 Changein Tax Rate Income Tax Expense Benefit TaxCutsandJobsActof2017ChangeinTaxRateIncomeTaxExpenseBenefit	55700000	USD
CY2017	pcrx	Total Changein Discontinued Operations Balance TotalChangeinDiscontinuedOperationsBalance	-567000	USD
CY2018	pcrx	Total Changein Discontinued Operations Balance TotalChangeinDiscontinuedOperationsBalance	-13000	USD
CY2016	pcrx	United States Statutory Tax Rate UnitedStatesStatutoryTaxRate	0.35
CY2017	pcrx	United States Statutory Tax Rate UnitedStatesStatutoryTaxRate	0.35
CY2018	pcrx	United States Statutory Tax Rate UnitedStatesStatutoryTaxRate	0.21
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14658000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14368000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31658000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	38000000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	41057000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	45865000	USD
CY2017Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	4091000	USD
CY2018Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2286000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	49210000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	61558000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-280000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	669032000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	709691000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-2000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	31248000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	31601000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	31725000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31248000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31601000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31725000	USD
CY2016	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4088000	USD
CY2017	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10423000	USD
CY2018	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	12799000	USD
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6816000	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6060000	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6065000	shares
CY2017Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	1500000	USD
CY2018Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2200000	USD
CY2018	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	100000	USD
CY2016Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	0	USD
CY2017Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	309000	USD
CY2018Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	282000	USD
CY2017	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	420000	USD
CY2018	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	91000	USD
CY2017Q4	us-gaap	Assets Assets	628371000	USD
CY2018Q4	us-gaap	Assets Assets	689353000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	391110000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	477969000	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh	10000000	USD
CY2017	us-gaap	Business Exit Costs1 BusinessExitCosts1	73000	USD
CY2018	us-gaap	Business Exit Costs1 BusinessExitCosts1	13000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56984000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35944000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54126000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132526000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40668877	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41222799	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40668877	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41222799	shares
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43035000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	41000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	41000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37927000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-297000	USD
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	900000	USD
CY2017Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	324000	USD
CY2018Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	338000	USD
CY2017Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	276173000	USD
CY2018Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	290592000	USD
CY2016	us-gaap	Cost Of Revenue CostOfRevenue	110104000	USD
CY2017Q1	us-gaap	Cost Of Revenue CostOfRevenue	24581000	USD
CY2017Q2	us-gaap	Cost Of Revenue CostOfRevenue	23811000	USD
CY2017Q3	us-gaap	Cost Of Revenue CostOfRevenue	18228000	USD
CY2017Q4	us-gaap	Cost Of Revenue CostOfRevenue	21295000	USD
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	87915000	USD
CY2018Q1	us-gaap	Cost Of Revenue CostOfRevenue	22885000	USD
CY2018Q2	us-gaap	Cost Of Revenue CostOfRevenue	20916000	USD
CY2018Q3	us-gaap	Cost Of Revenue CostOfRevenue	19065000	USD
CY2018Q4	us-gaap	Cost Of Revenue CostOfRevenue	23979000	USD
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	86845000	USD
CY2017	us-gaap	Costs Incurred Asset Retirement Obligation Incurred CostsIncurredAssetRetirementObligationIncurred	656000	USD
CY2018	us-gaap	Costs Incurred Asset Retirement Obligation Incurred CostsIncurredAssetRetirementObligationIncurred	51000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	1361000	USD
CY2017Q1	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	300000	USD
CY2018Q2	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	100000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	11000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-96000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	94000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	140000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	142000	USD
CY2017	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	2500000	shares
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	6800000	USD
CY2018Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	6900000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	102000	USD
CY2018Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1841000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	134908000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	130313000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	552000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	848000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	95067000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	79446000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	139000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	127000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	11009000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	120230000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2593000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2851000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	15048000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	17730000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	2743000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	118658000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	14678000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	11655000	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1500000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1300000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1600000	USD
CY2016	us-gaap	Depreciation Depreciation	12800000	USD
CY2017	us-gaap	Depreciation Depreciation	13800000	USD
CY2018	us-gaap	Depreciation Depreciation	13200000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12919000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13833000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13165000	USD
CY2016Q4	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	0	USD
CY2017Q4	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	2077000	USD
CY2018Q4	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	2252000	USD
CY2016	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	USD
CY2017	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-4868000	USD
CY2018	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-1564000	USD
CY2017	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	5400000	USD
CY2018	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	1600000	USD
CY2017	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	1467000	USD
CY2018	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	1402000	USD
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.02
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.52
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.49
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.19
CY2017Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.11
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.07
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.06
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2018Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.20
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0028
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0033
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.1073
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.4396
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.0458
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	3.6927
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0000
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-1.3296
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0054
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0121
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	8.7429
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0204
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0790
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0615
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0220
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0226
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.2484
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0877
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0496
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-7.0035
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12295000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	16974000	USD
CY2016	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-389000	USD
CY2017	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-2133000	USD
CY2018	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-65000	USD
CY2016	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2017	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2018	us-gaap	Gain Loss On Investments GainLossOnInvestments	-854000	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3732000	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3700000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016Q4	us-gaap	Goodwill Goodwill	46737000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	55197000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	62040000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-36339000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-39898000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	5169000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37844000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-42471000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-425000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1505000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2573000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-5594000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	105000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	140000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	247000	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	129000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	128000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-350000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5712000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-573000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4082000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1721000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5999000	USD
CY2016	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1060000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3647000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5203000	USD
CY2018	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations	400000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-30367000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10133000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7157000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1339000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3555000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	897000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3377000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3476000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3228000	USD
CY2016	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1491000	USD
CY2016	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1500000	USD
CY2017	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1101000	USD
CY2017	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1100000	USD
CY2018	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	689000	USD
CY2018	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	700000	USD
CY2016	us-gaap	Interest Expense InterestExpense	7061000	USD
CY2017	us-gaap	Interest Expense InterestExpense	18047000	USD
CY2018	us-gaap	Interest Expense InterestExpense	21949000	USD
CY2016	us-gaap	Interest Paid InterestPaid	3852000	USD
CY2017	us-gaap	Interest Paid InterestPaid	6896000	USD
CY2018	us-gaap	Interest Paid InterestPaid	8205000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	16540000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	19665000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	41411000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	48569000	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16500000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19193000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8371000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9711000	USD
CY2016	us-gaap	Inventory Write Down InventoryWriteDown	20700000	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	1323000	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	4078000	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	6497000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	348888000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	368127000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	628371000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	689353000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	56217000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	60661000	USD
CY2017Q4	us-gaap	Long Term Investments LongTermInvestments	60047000	USD
CY2018Q4	us-gaap	Long Term Investments LongTermInvestments	25871000	USD
CY2016	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-21040000	USD
CY2017	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	18182000	USD
CY2018	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	78400000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	7261000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	224162000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	8954000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-61754000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-223765000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	20576000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	33453000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	17785000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	48870000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-37949000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-19866000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-19743000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-7597000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	4595000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-42611000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-10680000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	2564000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-640000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	8285000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-471000	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5820000	USD
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17534000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16340000	USD
CY2018	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2016	us-gaap	Operating Expenses OperatingExpenses	308395000	USD
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	83333000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	86714000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	70907000	USD
CY2017Q4	us-gaap	Operating Expenses OperatingExpenses	70613000	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	311567000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	81544000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	77566000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	79400000	USD
CY2018Q4	us-gaap	Operating Expenses OperatingExpenses	82852000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	321362000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-32024000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	15915000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	46345000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-24937000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	8140000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	5543000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	5417000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	5295000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7621000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	14329000	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	6000000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	7500000	USD
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	7200000	USD
CY2017	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	494000	USD
CY2018	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	0	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	825000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	657000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	22000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-424000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	174000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	22000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-424000	USD
CY2018	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	174000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16498000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16874000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-82000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	167000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-888000	USD
CY2017	us-gaap	Payments For Postemployment Benefits PaymentsForPostemploymentBenefits	303000	USD
CY2018	us-gaap	Payments For Postemployment Benefits PaymentsForPostemploymentBenefits	0	USD
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11000000	USD
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2016	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	0	USD
CY2017	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	15000000	USD
CY2018	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	0	USD
CY2017Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15000000	USD
CY2016	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	192815000	USD
CY2017	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	502752000	USD
CY2018	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	363255000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24709000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19266000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14514000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6694000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7946000	USD
CY2016	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2017	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	345000000	USD
CY2018	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2016	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	171627000	USD
CY2017	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	321713000	USD
CY2018	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	405188000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5770000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6778000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7170000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	156256000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	170228000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	107046000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	108670000	USD
CY2018Q4	us-gaap	Purchase Obligation PurchaseObligation	24500000	USD
CY2018	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	900000	USD
CY2016	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	4000	USD
CY2017	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	118193000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45678000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	57290000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	55688000	USD
CY2016	us-gaap	Restricted Stock Expense RestrictedStockExpense	5117000	USD
CY2017	us-gaap	Restricted Stock Expense RestrictedStockExpense	6698000	USD
CY2018	us-gaap	Restricted Stock Expense RestrictedStockExpense	8371000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-389136000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-388226000	USD
CY2016	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	270073000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	284342000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	332427000	USD
CY2016	us-gaap	Revenues Revenues	276371000	USD
CY2017Q1	us-gaap	Revenues Revenues	69283000	USD
CY2017Q2	us-gaap	Revenues Revenues	70934000	USD
CY2017Q3	us-gaap	Revenues Revenues	67335000	USD
CY2017Q4	us-gaap	Revenues Revenues	79078000	USD
CY2017	us-gaap	Revenues Revenues	286630000	USD
CY2018Q1	us-gaap	Revenues Revenues	74607000	USD
CY2018Q2	us-gaap	Revenues Revenues	84107000	USD
CY2018Q3	us-gaap	Revenues Revenues	83448000	USD
CY2018Q4	us-gaap	Revenues Revenues	95115000	USD
CY2018	us-gaap	Revenues Revenues	337277000	USD
CY2016	us-gaap	Royalty Revenue RoyaltyRevenue	2872000	USD
CY2017	us-gaap	Royalty Revenue RoyaltyRevenue	1901000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	161494000	USD
CY2018	us-gaap	Royalty Revenue RoyaltyRevenue	1850000	USD
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	270073000	USD
CY2017	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	284342000	USD
CY2018	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	332427000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	152613000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	177265000	USD
CY2017	us-gaap	Severance Costs1 SeveranceCosts1	303000	USD
CY2018	us-gaap	Severance Costs1 SeveranceCosts1	0	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	31248000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	31601000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	31725000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	12129537	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1677552	shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	10451985	shares
CY2018Q4	us-gaap	Share Price SharePrice	43.02
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	257221000	USD
CY2018Q4	us-gaap	Short Term Investments ShortTermInvestments	250928000	USD
CY2018	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	224887	shares
CY2017	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	120960000	USD
CY2016	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1495000	USD
CY2017	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1862000	USD
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1784000	USD
CY2016	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2017	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2018	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5770000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6778000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7170000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	218392000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	218976000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	279483000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	321226000	USD
CY2017Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	14146000	USD
CY2018Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	14146000	USD
CY2018Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	14000000	USD
CY2016Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	0	USD
CY2017Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	0	USD
CY2018Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	0	USD
CY2017Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	76000	USD
CY2018Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	90000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2473000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2881000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2900000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	400000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	408000	USD
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	800000	USD
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-28500000	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1600000	USD
CY2016	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	12871000	USD
CY2017	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	15581000	USD
CY2018	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	19321000	USD
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3900000	USD
CY2016Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3800000	USD
CY2017Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3013000	USD
CY2018Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3300000	USD
CY2016	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	12971000	USD
CY2017	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	16368000	USD
CY2018	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	19034000	USD
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37236000	shares
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39806000	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40911000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37236000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39806000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40911000	shares
CY2018	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recent Accounting Pronouncements Not Adopted as of December 31, 2018</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font><font style="font-family:inherit;font-size:10pt;"> and subsequently issued clarifications and corrections to the update by issuing ASU 2018-10 in July 2018. This update requires lessees to recognize lease assets and lease liabilities on the consolidated balance sheet for those leases classified as operating leases under previous authoritative guidance. Upon adoption, the lease liability will be equal to the present value of future lease payments and a right-of-use, or ROU, asset will be based on the lease liability, subject to adjustment for items such as initial direct costs. For income statement purposes, the new standard retains a dual model similar to ASC 840, requiring leases to be classified as either operating or financing. Operating leases will continue to result in straight-line expense while financing leases will result in a front-loaded expense pattern (similar to current accounting guidance by lessees for operating and capital leases, respectively, under ASC 840). </font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There are a number of practical expedients available to the Company at transition. The transition practical expedients are that the Company may elect to not re-assess: (i) whether its contracts contain a lease under the new definition, (ii) the classification of those leases and (iii) the accounting for any initial direct costs previously incurred. In addition, the Company may apply hindsight in determining the lease terms and in assessing a purchase option on its existing leases and any potential impairments that may exist on the ROU assets to be recognized at adoption. The Company may also elect to not recognize an ROU asset and lease liability for those leases with a remaining lease term of 12 months or less. The Company will apply these practical expedients upon adoption.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon adoption, ROU assets and lease liabilities are being recognized on the Company’s consolidated balance sheets. The lease liability recognized upon adoption is based upon the present value of the sum of the remaining minimum lease payments (as previously identified under ASC 840) and any amounts probable of being owed under a residual value guarantee (if applicable), to be determined using the discount rate then in effect. The interest rate is based on the Company’s ability to borrow on a collateralized basis over a similar remaining term and in a similar economic environment. The ROU asset to be recorded is based on the lease liability and adjusted for any prepaid or accrued lease payments, the remaining balance of any lease incentives, initial indirect costs and impairments (if applicable). </font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The standard is effective for the Company beginning January 1, 2019. The Company elected to adopt the new standard at the beginning of the period of adoption through a cumulative-effect adjustment. The Company will reflect its ROU assets, lease liabilities and any cumulative-effect adjustment to retained earnings in its consolidated financial statements beginning on January 1, 2019.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company continues to evaluate the impact of ASU 2016-02 on its consolidated financial statements. The recognition of lease liabilities and corresponding ROU assets is expected to have a material impact on the Company’s consolidated balance sheet. The Company estimates that it will record approximately </font><font style="font-family:inherit;font-size:10pt;">$35.0 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$38.0 million</font><font style="font-family:inherit;font-size:10pt;"> of lease liabilities and </font><font style="font-family:inherit;font-size:10pt;">$26.0 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$29.0 million</font><font style="font-family:inherit;font-size:10pt;"> of ROU assets as of January 1, 2019, the difference representing previously recorded lease-related assets and liabilities. The Company does not believe the adoption of this standard will have a material impact on its consolidated statements of operations, stockholders’ equity or cash flows. Refer to Note 18, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Commitments and Contingencies</font><font style="font-family:inherit;font-size:10pt;">, for further information on the Company’s existing leases.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</font><font style="font-family:inherit;font-size:10pt;">, which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. Entities will now use forward-looking information to better form their credit loss estimates. This update also requires enhanced disclosures to help financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. This standard will become effective for the Company beginning January 1, 2020, with early adoption permitted. The Company is currently evaluating the impact of ASU 2016-13 on its consolidated financial statements.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU 2018-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement (Topic 820): Disclosure Framework. </font><font style="font-family:inherit;font-size:10pt;">The purpose of the update is to improve the effectiveness of the fair value measurement disclosures that allows for clear communication of information that is most important to the users of financial statements. There were certain required disclosures that have been removed or modified. In addition, the update added the following disclosures: (i) changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and (ii) the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The standard will become effective for the Company beginning January 1, 2020, with early adoption permitted. The Company is currently evaluating the impact of ASU 2018-13 on its consolidated financial statements.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU 2018-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles—Goodwill and Other Internal-Use Software (Subtopic 350-40: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract</font><font style="font-family:inherit;font-size:10pt;">, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update provides guidance to determine which implementation costs to capitalize as they relate to the service contract and which costs to expense. In addition, the update further defines the term of the hosting arrangement to include the non-cancelable period of the arrangement plus periods covered by (i) an option to extend the arrangement if the customer is reasonably certain to exercise that option; (ii) an option to terminate the arrangement if the customer is reasonably certain not to exercise the termination option and (iii) an option to extend (or not to terminate) the arrangement in which exercise of the option is in the control of the vendor. Any expense related to the capitalized implementation costs should be recorded in the same financial statement line item in the consolidated statements of operations as the fees associated with the hosting element of the arrangement, and the payments for capitalized implementation costs should be classified in the same manner as payments made for fees associated with the hosting element in the consolidated statements of cash flows. This standard will become effective for the Company beginning January 1, 2020. The amendments may be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company is currently evaluating the impact of ASU 2018-15 on its consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or not significant to the consolidated financial statements of the Company.</font></div></div>
CY2018	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, among other things, revenue recognition, inventory costs, impairments of equity investments, long-lived assets, goodwill, liabilities and accruals and the valuation of deferred tax assets. The Company’s critical accounting policies are those that are both most important to the Company’s consolidated financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results could differ from these estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001396814-19-000008-index-headers.html	Edgar Link	pending
0001396814-19-000008-index.html	Edgar Link	pending
0001396814-19-000008.txt	Edgar Link	pending
0001396814-19-000008-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
item5colorcharta04.jpg	Edgar Link	pending
paciralogoa10.jpg	Edgar Link	pending
pcrx-12312018x10k.htm	Edgar Link	pending
pcrx-12312018xex1041.htm	Edgar Link	pending
pcrx-12312018xex211.htm	Edgar Link	pending
pcrx-12312018xex231.htm	Edgar Link	pending
pcrx-12312018xex311.htm	Edgar Link	pending
pcrx-12312018xex312.htm	Edgar Link	pending
pcrx-12312018xex321.htm	Edgar Link	pending
pcrx-12312018xex322.htm	Edgar Link	pending
pcrx-20181231.xml	Edgar Link	completed
pcrx-20181231.xsd	Edgar Link	pending
pcrx-20181231_cal.xml	Edgar Link	unprocessable
pcrx-20181231_def.xml	Edgar Link	unprocessable
pcrx-20181231_lab.xml	Edgar Link	unprocessable
pcrx-20181231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira BioSciences, Inc. Stock $pcrx

2017 Q4 Form 10-K Financial Statement

#000139681419000008 Filed on February 28, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira BioSciences, Inc. Stock $pcrx

2017 Q4 Form 10-K Financial Statement

#000139681419000008 Filed on February 28, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira BioSciences, Inc. Stock $pcrx